Friday, December 1, 2023

What type of drug is fluralaner?

 key words:  fluralaner,CAS NO 864731-61-3,fluralaner specification

Fluralaner is a potent acaricide and insecticide from the isoxazoline drug class.

Fluralaner works mainly by interfering with GABA-gated chloride channels, similar to the targets of insecticides such as cyclopentadienes, phenylpyrazoles and macrolides.

Fluralaner is a broad-spectrum pesticide with good insecticidal activity against pests such as ticks, fleas, lice, hemiptera, and diptera. It is more virulent than or comparable to commonly used pesticides.


Items

Specifications

Results

Appearance

White to light yellow powder

Conforms

Solubility

Freely soluble in ethyl acetate or DMF.

0.79%

Identification

The retention time of the major peak of the sample solution corresponds to that of the standard solution,as obtained in the Assay.

Conforms

Water

Not more than 1.0%

Conforms

Organic impurities

Individual unspecified impurity not more than 0.20%

Conforms

Total impurities not more than 1.0%

Conforms

Residual solvent

Dichloromethane not more than 0.060%

0.0078%

N-hexane not more than 0.029%

0.0052%

Ethyl acetate not more than 0.50%

0.012%

Tetrahydrofuran not more than 0.072 %

Not detected

Triethylamine not more than 0.50%

Not detected

Toluene not more than 0.089%

0.012%

DMF not more than 0.088 %

Not detected

Residue on ignition

Not more than 0.20%

0.00068%

Heavy metal

Not more than 20ppm

Not detected

Assay

NLT 98.0% and NMT 102.0% of C22H17Cl2F6N3O3,calculated on the anhydrous basis.

100.8%

Conclusion

The product conforms to above standard.


Welcome to Contact Us to get more details.                     

Wuhan Fortuna Chemical Co., Ltd.

Name: Ishara Zhang

Title: Senior Sales Export

Mobile:  +86-18007136271

WhatsApp: 18007136271

Skype:  fortunachem201302

E-mail:  hk@fortunachem.com 

Website:  www.fortunachem.com

 Zip code:  430013

Address:  Room 2015-2016, No. 2 Building, Kaixing Mansion,  No. 107 Jinqiao Avenue,  Wuhan,Hubei, China

 


No comments:

Post a Comment